MENU
VTGN
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

VistaGen Therapeutics (VTGN) Ownership - Who owns VistaGen Therapeutics?

Vistagen Therapeutics Inc is a biotechnology firm... Show more

Industry: #Biotechnology

Profile

Industry
Biotechnology
Address
343 Allerton Avenue
Phone
+1 650 577-3600
Employees
33
Web
https://www.vistagen.com

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
28.75M
P/E Ratio
N/A
Total Cash
77.18M
Projected Growth
N/A
Total Debt
1.87M
Revenue
721K
Risk (Beta)
0.94
Dividend Yield
N/A
Total Cash/Share
1.95
Total Debt/Equity
N/A
Revenue/Share
0.02 USD as % of share price

Fundamentals

VTGN
Capitalization
28.7M
P/E Ratio
N/A
Risk (Beta)
0.94
Dividend Yield
N/A
Total Cash
77.2M
Total Cash/Share
1.95
Total Debt
1.87M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0.02%
Revenue
721K
ROE
N/A
Book Value
66.3M
P/B Ratio
0.43
Cash Flow
N/A
Earnings
-1.92
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
39K
Current Ratio
5.79
Current Revenue Per Employee
4372.88
Dividends Per Share - Security
N/A
EBITDA
-64.79M
Float
N/A
Float - Current
N/A
Gross Income Margin
100.00
Revenue To Assets
-67.86
Shares Held By Institutions
87.6M
Shares Outstanding - Current
39.5M
Total Liabilities
14.6M
Total Volume MTD
N/A
Value
1
Gain YTD
-75.325
View a ticker or compare two or three
VTGN
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period.
A.I. Advisor
published General Information

General Information

a developer of embryonic stem cells for drug discovery and development

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Biotechnology
Address
343 Allerton Avenue
Phone
+1 650 577-3600
Employees
33
Web
https://www.vistagen.com